Key points
- The mainstay of treatment for myeloma is to receive several drugs in combination
- Through the course of their myeloma, patients may receive the same treatment more than once, particularly if they showed a good response to that treatment previously and did not progress whilst receiving the treatment or shortly thereafter
- No treatment for myeloma is currently considered to be curative
- Some patients will receive one or more autologous stem cell transplants
- Patients may respond differently to the same treatment, despite being at the same disease stage
- A patient’s age, any pre-existing medical conditions and personal preferences must all be taken into consideration in treatment decisions
- Nurses play a crucial role in ensuring that patients and their families are kept informed about their treatment options throughout the different stages of their disease
- Almost all treatments for myeloma bring side effects. You can read more about how nurses can help manage these side effects in Module 8 of this programme and in our Myeloma Nurse Guide series.
- Quality of life should always be factored into treatment decisions and patients should feel able to discuss their concerns with their medical team, particularly during later lines of therapy
- You can find more information on all drugs discussed here on Patient Information Hub.